Addex and Perceptive Launch Neurosterix with $63 Million to

Addex receives CHF5M and 20% share of Neurosterix  Perceptive Advisors leads $63M investment into Neurosterix  Addex contributes portfolio of preclinical neuroscience assets and...

Related Keywords

United States , Switzerland , New York , Geneva , Genè , Swiss , American , Addex Neurosterix , Fred Callori , Jean Philippe Rocher , Mike Sinclair , Robert Lutjens , Tim Dyer , Mikhail Kalinichev , Perceptive Life Sciences Fund , Janssen Pharmaceuticals Inc , Swiss Exchange , Nasdaq , Perceptive Xontogeny Venture Fund , Hoc Announcement Pursuant , Perceptive Advisors , Acorn Bioventures , Janssen Pharmaceuticals , Managing Director , Addex Executive , Addex Executive Management , Translational Science , Executive Management , Perceptive Xontogeny Venture Funds , Perceptive Advisor , American Depositary Shares , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutics , Addex Therapeutic , Markets ,